Quantcast

Latest Aliskiren Stories

2014-09-08 08:32:02

DENVER, Sept. 8, 2014 /PRNewswire/ -- Silvergate Pharmaceuticals, Inc. (www.Silvergatepharma.com), focused on the development and commercialization of innovative and safe medicines for children, today announced that the United States Food and Drug Administration (FDA) approved Epaned® (enalapril maleate Powder for Oral Solution) for the treatment of symptomatic heart failure and the treatment of asymptomatic left ventricular dysfunction (to decrease the rate of development of overt heart...

2013-09-04 08:31:01

AQUARIUS trial data show Aliskiren reduced incidents of death, stroke, heart attack Patients with clogged and hardened arteries who already have their blood pressure under control may benefit from an additional blood pressure-lowering medication, according to research from the Cleveland Clinic Coordinating Center for Clinical Research (C5Research). The researchers found that the renin-inhibitor aliskiren tended to slow coronary disease progression and reduced the risk of death, stroke...

2013-04-18 23:19:17

d´Oliveira & Associates has issued a new infographic providing information on a Tekturna medical study that was stopped due to patients suffering from nonfatal stroke, hyperkalemia, and hypotension. (PRWEB) April 18, 2013 Tekturna (aliskiren), produced by Novartis, is a once-daily pill used to treat high blood pressure (hypertension) and is the first “Renin Inhibitor” drug that regulates the renin enzyme in the kidney. This process assists by narrowing the blood...

2012-11-05 15:04:16

Studies investigate the potential of several drugs for the treatment of patients with diabetes or kidney disease Three late-breaking studies presented during the American Society of Nephrology's Annual Kidney Week provide new information on drugs being tested in patients with diabetes or kidney disease. Hans-Henrik Parving, MD (University of Copenhagen, in Denmark) and his colleagues investigated whether the drug aliskiren might improve the prognosis of patients with type 2 diabetes who...

2012-09-11 22:25:52

Nearly 5 percent of pregnant women are prescribed drugs to treat high blood pressure, including some drugs that aren't considered safe for mothers or their babies, according to new research in the American Heart Association's journal Hypertension. Use of high blood pressure drugs during pregnancy is becoming increasingly common, said Brian T. Bateman, M.D., lead author and Assistant Professor of anesthesia at Harvard Medical School in Boston, Mass. "While we know high blood pressure, or...

2012-03-22 21:17:45

Drug manufacturer deviates from the appropriate comparator therapy specified by the G-BA The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the "Act on the Reform of the Market for Medicinal Products” (AMNOG), the German Institute for Quality and Efficiency in Health Care...

2012-01-12 21:02:24

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications. The pharmaceutical company Novartis terminated a large, international clinical trial of the drug last month after finding an increased incidence after 18-24 months of non-fatal strokes, renal complications, high levels of potassium in the blood and low blood pressure. As a result,...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'